{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05482464",
            "orgStudyIdInfo": {
                "id": "IRB-2021-1186"
            },
            "organization": {
                "fullName": "Oregon State University",
                "class": "OTHER"
            },
            "briefTitle": "Effect of Daily Consumption of Glycomacropeptide on Gut Microbiome and Blood Functional Proteome of Subjects With Irritable Bowel Syndrome",
            "officialTitle": "Effect of Daily Consumption of Glycomacropeptide on Gut Microbiome and Blood Functional Proteome of Subjects With Irritable Bowel Syndrome",
            "therapeuticArea": [
                "Immunology and Rheumatology"
            ],
            "study": "effect-of-daily-consumption-of-glycomacropeptide-on-gut-microbiome-and-blood-functional-proteome-of-subjects-with-irritable-bowel-syndrome"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-01-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-04-06",
            "studyFirstSubmitQcDate": "2022-07-28",
            "studyFirstPostDateStruct": {
                "date": "2022-08-01",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-07-28",
            "lastUpdatePostDateStruct": {
                "date": "2022-08-01",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Dave Dallas",
                "investigatorTitle": "Assistant Professor",
                "investigatorAffiliation": "Oregon State University"
            },
            "leadSponsor": {
                "name": "Oregon State University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "BUILD Dairy",
                    "class": "UNKNOWN"
                },
                {
                    "name": "Agropur",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study investigates the use of glycomacropeptide (GMP) as a means to manipulate the gut microbiome, metabolome and protein profile of subjects with irritable bowel syndrome (IBS).",
            "detailedDescription": "In vitro assays show that GMP strongly promotes the growth of beneficial bacteria including Bifidobacterium breve, B. bifidum, B. infantis and Lactococcus lactis. GMP also binds to pathogenic bacteria and prevents their adhesion to intestinal cells, which could prevent enteric infection. GMP also modulates the inflammatory response of key gut immune cells called macrophages. However, the extent to which daily consumption of GMP alters the gut microbiome, metabolome and protein profile of subjects with IBS remains unknown.\n\nThis study will investigate how daily GMP consumption can alter the gut microbiome, metabolome and protein profile of subjects with IBS."
        },
        "conditionsModule": {
            "conditions": [
                "Inflammatory Bowel Syndrome"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "single group assignment",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 15,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Casein glycomacropeptide (CGMP)",
                    "type": "OTHER",
                    "description": "The subjects will receive a daily oral intake of CGMP-protein-shake for 3 weeks with a 1 week wash-in and a 3 week wash-out.\n\nIntervention: Dietary Supplement: Casein glycomacropeptide (CGMP)",
                    "interventionNames": [
                        "Dietary Supplement: Casein glycomacropeptide (CGMP)"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DIETARY_SUPPLEMENT",
                    "name": "Casein glycomacropeptide (CGMP)",
                    "description": "Casein glycomacropeptide (CGMP) supplementation for 3 weeks",
                    "armGroupLabels": [
                        "Casein glycomacropeptide (CGMP)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Measure the inflammatory markers in stool and blood using immunology multiplex assay",
                    "description": "Change in levels of inflammatory markers (GM-CSF, IFN-\u03b3, IL-1\u03b2, IL-2, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (p70), IL-13, IL-15, IL-17A, IL-17F, IL-17E/IL-25, IL-21, IL-22, IL-23, IL-27, IL-28A, IL-31, IL-33, MIP-3\u03b1/CCL20, TNF-\u03b1 and TNF\u03b2) in stool and blood using immunology multiplex assay",
                    "timeFrame": "Baseline, GMP feeding week 1, 2 and 3 and post study without GMP feeding week 1, 2 and 3"
                },
                {
                    "measure": "Stool sample based gut microbiome composition using 16S rRNA gene sequencing",
                    "description": "Change in stool sample based gut microbiome composition using 16S rRNA gene sequencing.",
                    "timeFrame": "Baseline, GMP feeding week 1, 2 and 3 and post study without GMP feeding week 1, 2 and 3"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Fluent in English\n* IBS diagnosis with Rome IV criteria\n* People who have a primary care provider\n\nExclusion Criteria:\n\n* Lactose or milk protein intolerance\n* Any known other gastrointestinal disease or disorder beyond IBS, or major gastrointestinal surgery\n* Habitual use of laxatives or antacids\n* Pregnant or nursing.\n* Use of pre or probiotics within one month prior to the study\n* Use of antibiotics within one month prior to the study",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "30 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "locations": [
                {
                    "facility": "Milam Hall, Room 001",
                    "status": "RECRUITING",
                    "city": "Corvallis",
                    "state": "Oregon",
                    "zip": "97331",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "David C Dallas, PhD",
                            "role": "CONTACT",
                            "phone": "541-737-1751",
                            "email": "dave.dallas@oregonstate.edu"
                        },
                        {
                            "name": "Yunyao Qu, MS",
                            "role": "CONTACT",
                            "email": "yunyao.qu@oregonstate.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.56457,
                        "lon": -123.26204
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000043183",
                    "term": "Irritable Bowel Syndrome"
                },
                {
                    "id": "D000013577",
                    "term": "Syndrome"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004194",
                    "term": "Disease"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000003109",
                    "term": "Colonic Diseases, Functional"
                },
                {
                    "id": "D000003108",
                    "term": "Colonic Diseases"
                },
                {
                    "id": "D000007410",
                    "term": "Intestinal Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "asFound": "Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M25118",
                    "name": "Irritable Bowel Syndrome",
                    "asFound": "Irritable Bowel Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6336",
                    "name": "Colonic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6337",
                    "name": "Colonic Diseases, Functional",
                    "relevance": "LOW"
                },
                {
                    "id": "M10444",
                    "name": "Intestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002364",
                    "term": "Caseins"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002614",
                    "term": "Chelating Agents"
                },
                {
                    "id": "D000064449",
                    "term": "Sequestering Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5616",
                    "name": "Caseins",
                    "asFound": "With water",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5860",
                    "name": "Chelating Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}